This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jordens, J. Z.
Right arrow Articles by Heckels, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jordens, J. Z.
Right arrow Articles by Heckels, J. E.

 Previous Article  |  Next Article 

Infection and Immunity, November 2004, p. 6503-6510, Vol. 72, No. 11
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.11.6503-6510.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Development of Immunity to Serogroup B Meningococci during Carriage of Neisseria meningitidis in a Cohort of University Students

J. Zoe Jordens ,1,2,{dagger},{ddagger} Jeannette N. Williams,1,{dagger} Graeme R. Jones,1,2 Myron Christodoulides,1 and John E. Heckels1*

Molecular Microbiology and Infection Group, Division of Infection, Inflammation and Repair, University of Southampton Medical School,1 Health Protection Agency, Southampton, United Kingdom2

Received 22 March 2004/ Returned for modification 18 May 2004/ Accepted 4 August 2004

Understanding the basis of protective immunity is a key requirement for the development of an effective vaccine against infection with Neisseria meningitidis of serogroup B. We have conducted a longitudinal study into the dynamics of meningococcal acquisition and carriage in first-year university students. The detection of carriage of serogroup B meningococci correlated with an increase in detection of serum bactericidal activity (SBA) against both colonizing and heterologous serogroup B strains. Once induced, SBA remained high throughout the study. Although students showed increases in antibodies reactive with capsular polysaccharide and lipopolysaccharide (LPS), these antibody responses were transitory, and their decline was not accompanied by a corresponding decline in SBA. In contrast, there was a significant correlation between the presence of antibodies to the PorA outer membrane protein and SBA against both homologous and heterologous strains. SBA induced by a PorA-negative mutant confirmed the contribution of PorA to heterologous activity. Increases in SBA against a range of serogroup B strains were also observed in students in whom no meningococcal carriage was detected. This heterologous protection could not be associated with the presence of antibodies reacting with capsule, LPS, PorA, PorB, Rmp, Opa, Opc, or pilin, demonstrating that other, as yet unidentified, antigens contribute to the development of immunity to serogroup B meningococci. Identification of such antigens with the ability to induce an effective cross-reactive bactericidal response to a range of strains would be a major step in the production of a universally effective vaccine against infections caused by serogroup B meningococci.

* Corresponding author. Mailing address: Molecular Microbiology and Infection, Mailpoint 814, Southampton General Hospital, Southampton SO16 6YD, United Kingdom. Phone: 44 23 80 796992. Fax: 44 23 80 796974. E-mail: jeh{at}soton.ac.uk.

Editor: J. N. Weiser

{dagger} J.Z.J. and J.N.W. contributed equally to the work.

{ddagger} Present address: Institute of Molecular BioSciences, Massey University, Palmerston North 5331, New Zealand.

Infection and Immunity, November 2004, p. 6503-6510, Vol. 72, No. 11
0019-9567/04/$08.00+0     DOI: 10.1128/IAI.72.11.6503-6510.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Williams, J. N., Skipp, P. J., O'Connor, C. D., Christodoulides, M., Heckels, J. E. (2009). Immunoproteomic Analysis of the Development of Natural Immunity in Subjects Colonized by Neisseria meningitidis Reveals Potential Vaccine Candidates. Infect. Immun. 77: 5080-5089 [Abstract] [Full Text]  
  • Morales-Aza, B., Glennie, S. J., Garcez, T. P., Davenport, V., Johnston, S. L., Williams, N. A., Heyderman, R. S. (2009). Impaired maintenance of naturally acquired T-cell memory to the meningococcus in patients with B-cell immunodeficiency. Blood 113: 4206-4212 [Abstract] [Full Text]  
  • Bayliss, C. D., Hoe, J. C., Makepeace, K., Martin, P., Hood, D. W., Moxon, E. R. (2008). Neisseria meningitidis Escape from the Bactericidal Activity of a Monoclonal Antibody Is Mediated by Phase Variation of lgtG and Enhanced by a Mutator Phenotype. Infect. Immun. 76: 5038-5048 [Abstract] [Full Text]  
  • Norheim, G., Aseffa, A., Yassin, M. A., Mengistu, G., Kassu, A., Fikremariam, D., Tamire, W., Merid, Y., Hoiby, E. A., Caugant, D. A., Fritzsonn, E., Tangen, T., Melak, B., Berhanu, D., Harboe, M., Kolberg, J., Rosenqvist, E. (2008). Specificity of Subcapsular Antibody Responses in Ethiopian Patients following Disease Caused by Serogroup A Meningococci. CVI 15: 863-871 [Abstract] [Full Text]  
  • Zhu, D., Williams, J. N., Rice, J., Stevenson, F. K., Heckels, J. E., Christodoulides, M. (2008). A DNA Fusion Vaccine Induces Bactericidal Antibodies to a Peptide Epitope from the PorA Porin of Neisseria meningitidis. Infect. Immun. 76: 334-338 [Abstract] [Full Text]  
  • Azurmendi, H. F., Vionnet, J., Wrightson, L., Trinh, L. B., Shiloach, J., Freedberg, D. I. (2007). Extracellular structure of polysialic acid explored by on cell solution NMR. Proc. Natl. Acad. Sci. USA 104: 11557-11561 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»